Search

AxoGen Inc

Slēgts

SektorsVeselības aprūpe

35.97 2.86

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

34.02

Max

35.2

Galvenie mērījumi

By Trading Economics

Ienākumi

18M

-1.5M

Pārdošana

8.3M

70M

EPS

-0.03

Peļņas marža

-2.174

Darbinieki

622

EBITDA

17M

-4K

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+52.29% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 28. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-10M

2.2B

Iepriekšējā atvēršanas cena

33.11

Iepriekšējā slēgšanas cena

35.97

AxoGen Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 19. okt. 23:56 UTC

AxoGen Inc is trading modestly lower in after-market hours, retracing from a brief rally that peaked above Monday's close.

2026. g. 16. okt. 20:07 UTC

AxoGen Inc shares fell sharply after earlier strength, reaching a session low late in the day and remaining significantly below its 20-day moving average.

2026. g. 15. okt. 20:41 UTC

AxoGen Inc shares are trading lower in after-market hours, continuing a significant decline since Thursday's close and reaching its lowest cumulative return.

2026. g. 14. okt. 23:01 UTC

AxoGen Inc shares are declining in after-market hours, continuing a trend amid broader market losses driven by inflation concerns and geopolitical tensions.

2026. g. 13. okt. 19:51 UTC

AxoGen Inc shares fell sharply amid high market volume, remaining significantly below their 20-day moving average and reflecting ongoing weakness in the health care equipment sector.

2026. g. 12. okt. 20:13 UTC

AxoGen Inc shares are trading lower in after-market hours, remaining flat since Monday's close and positioned below its 20-day moving average amid sector weakness.

2026. g. 8. okt. 19:24 UTC

AxoGen Inc shares are declining amid broader market weakness, remaining notably below their 20-day moving average and sharply lower from a month ago.

2026. g. 7. okt. 20:12 UTC

AxoGen Inc advanced in after-market trading, gaining ground since Wednesday's close, despite a recent trend of finishing lower in the previous seven sessions.

2026. g. 6. okt. 20:00 UTC

AxoGen Inc shares fell sharply, continuing a downward trend with six consecutive sessions of losses and unusually high market volume.

2026. g. 5. okt. 21:30 UTC

AxoGen Inc. is trading modestly higher in after-market hours, recovering from a slight dip earlier in the session but remains below its 20-day moving average.

2026. g. 2. okt. 20:00 UTC

News

AxoGen Inc shares fell sharply despite completing its acquisition of BioCircuit Technologies, with unusually high trading volume observed today.

2026. g. 1. okt. 21:01 UTC

AxoGen Inc is seeing a significant decline in after-market trading, now notably below its 20-day moving average, indicating unusual weakness.

2026. g. 30. sept. 20:05 UTC

AxoGen Inc shares fell sharply, hitting a midday low and remaining significantly below its 20-day moving average during Wednesday's session.

2026. g. 29. sept. 20:07 UTC

AxoGen Inc shares fell sharply, closing notably down since Monday's close and remaining below its 20-day moving average amid significant volatility.

2026. g. 25. sept. 20:07 UTC

News

AxoGen Inc shares are higher as Raymond James raises its price target to $53, reflecting confidence in the company's growth potential amid a market rally.

2026. g. 24. sept. 20:31 UTC

AxoGen Inc. has advanced in after-market trading, recovering from a low point earlier in the session and reaching its highest cumulative return since Thursday's close.

2026. g. 23. sept. 19:46 UTC

AxoGen Inc shares fell significantly, remaining well below their 20-day moving average and near the lower end of their one-month range.

2026. g. 22. sept. 21:01 UTC

AxoGen Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

2026. g. 21. sept. 20:01 UTC

AxoGen Inc shares are experiencing significant upward movement, maintaining strong performance despite a slight pullback from a mid-day peak and unusually high trading volume.

2026. g. 18. sept. 19:52 UTC

AxoGen Inc shares fell sharply, experiencing unusually high trading volume and currently positioned near the low end of its one-month range.

2026. g. 17. sept. 23:06 UTC

AxoGen Inc is up in after-market trading, reaching a high of 1.04% above its prior close, despite remaining below its 20-day moving average.

2026. g. 16. sept. 21:41 UTC

AxoGen Inc is trading higher in after-market hours following Wednesday's close, maintaining a steady position despite being below its 20-day moving average.

2026. g. 15. sept. 20:07 UTC

AxoGen Inc shares are advancing during Tuesday's session, reflecting a broader positive market trend despite early volatility. The stock remains below its 20-day moving average.

2026. g. 14. sept. 22:56 UTC

AxoGen Inc shares are higher in after-market trading, recovering from earlier lows despite no specific news. Major indices declined amid rising crude oil prices.

2026. g. 11. sept. 20:13 UTC

AxoGen Inc shares are lower in after-market hours with no specific news identified. Recent inflation data has raised speculation about a Federal Reserve rate hike.

2026. g. 10. sept. 20:03 UTC

News
Social Media
Event

AxoGen Inc shares are lower after announcing a public offering of 4.91 million shares at $42.50 to fund its $200 million acquisition of BioCircuit Technologies.

2026. g. 8. sept. 20:07 UTC

News

AxoGen Inc shares are lower today, continuing a downward trend amid speculation of an interest rate hike following a stronger-than-expected jobs report.

2026. g. 3. sept. 19:56 UTC

AxoGen Inc shares are lower, extending a five-session decline amid broader market dynamics and a drop in Treasury yields following jobless claims data.

2026. g. 2. sept. 20:01 UTC

AxoGen Inc shares are lower today, marking four consecutive sessions of declines. Broader market sentiment is affected by a disappointing ADP employment report.

2026. g. 1. sept. 20:09 UTC

News

AxoGen Inc shares are lower today, continuing a decline since Monday amid rising oil prices and inflation concerns affecting the health care equipment sector.

Salīdzinājums

Cenas izmaiņa

AxoGen Inc Prognoze

Cenas mērķis

By TipRanks

52.29% augšup

Prognoze 12 mēnešiem

Vidējais 53.667 USD  52.29%

Augstākais 58 USD

Zemākais 48 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi AxoGen Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

12

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat